Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenming Liu

Showing results (91-100 of 167) with videos related to

Pageof 17
Sort By:
Bioorganic & Medicinal Chemistry|September 18, 2007
The design and synthesis of N-1-alkylated-5-aminoarylalkylsubstituted-6-methyluracils as potential non-nucleoside HIV-1 RT inhibitorsXiao Lu, Yanli Chen, Ying Guo, et al.
European Journal of Medicinal Chemistry|July 1, 2020
Rational modification, synthesis and biological evaluation of 3,4-dihydroquinoxalin-2(1H)-one derivatives as potent and selective c-Jun N-terminal kinase 3 (JNK3) inhibitorsXiaodong Dou, Huixia Huang, Lan Jiang, et al.
Molecular Cancer Therapeutics|November 6, 2025
Augmenting chemokine CCL21 enhances the effectiveness of CTLA4 blockade immunotherapy for head and neck squamous carcinomaHuiyu Liu, Xiaojiao Sun, Zhiqi Wang, et al.
Chemical Biology & Drug Design|February 15, 2013
Indolizine derivatives as HIV-1 VIF-ElonginC interaction inhibitorsWenlin Huang, Tao Zuo, Xiao Luo, et al.
Journal of Cellular Physiology|May 2, 2020
p120-catenin suppresses proliferation and tumor growth of oral squamous cell carcinoma via inhibiting nuclear phospholipase C-γ1 signalingLusha Li, Shangli Ji, Chandrama Shrestha, et al.
Journal of Medicinal Chemistry|March 4, 2025
Development of Potent SHP2 Allosteric Inhibitors: Design, Synthesis, and Evaluation with Antitumor EffectsCheng Shi, Yanping Zhao, Han Huang, et al.
Journal of Medicinal Chemistry|February 18, 2025
Structure-Based Discovery of a Highly Selective, Oral Polo-Like Kinase 1 Inhibitor with Potent Antileukemic ActivityJianyu Nie, Xiaojiao Sun, Yan He, et al.
RSC Advances|May 11, 2022
Discovery of acylphloroglucinol-based meroterpenoid enantiomers as KSHV inhibitors from <i>Hypericum japonicum</i>Linzhen Hu, Yanfei Liu, Yanxing Wang, et al.
European Journal of Medicinal Chemistry|August 20, 2021
Design, synthesis and biological activities of benzo[d]imidazo[1,2-a]imidazole derivatives as TRPM2-specfic inhibitorsSiqi Zhao, Han Zhang, Hongwei Jin, et al.
Chemistry & Biodiversity|February 24, 2026
Design, Synthesis, and Bioactivity Evaluation of a Palmitoyltransferase Inhibitor Based on the PAP StructureYibo Zhang, Han Liu, Jinze Li, et al.
Pageof 17

Showing results (91-100 of 167) with videos related to

Sort By:
Pageof 17
Bioorganic & Medicinal Chemistry|September 18, 2007
The design and synthesis of N-1-alkylated-5-aminoarylalkylsubstituted-6-methyluracils as potential non-nucleoside HIV-1 RT inhibitorsXiao Lu, Yanli Chen, Ying Guo, et al.
European Journal of Medicinal Chemistry|July 1, 2020
Rational modification, synthesis and biological evaluation of 3,4-dihydroquinoxalin-2(1H)-one derivatives as potent and selective c-Jun N-terminal kinase 3 (JNK3) inhibitorsXiaodong Dou, Huixia Huang, Lan Jiang, et al.
Molecular Cancer Therapeutics|November 6, 2025
Augmenting chemokine CCL21 enhances the effectiveness of CTLA4 blockade immunotherapy for head and neck squamous carcinomaHuiyu Liu, Xiaojiao Sun, Zhiqi Wang, et al.
Chemical Biology & Drug Design|February 15, 2013
Indolizine derivatives as HIV-1 VIF-ElonginC interaction inhibitorsWenlin Huang, Tao Zuo, Xiao Luo, et al.
Journal of Cellular Physiology|May 2, 2020
p120-catenin suppresses proliferation and tumor growth of oral squamous cell carcinoma via inhibiting nuclear phospholipase C-γ1 signalingLusha Li, Shangli Ji, Chandrama Shrestha, et al.
Journal of Medicinal Chemistry|March 4, 2025
Development of Potent SHP2 Allosteric Inhibitors: Design, Synthesis, and Evaluation with Antitumor EffectsCheng Shi, Yanping Zhao, Han Huang, et al.
Journal of Medicinal Chemistry|February 18, 2025
Structure-Based Discovery of a Highly Selective, Oral Polo-Like Kinase 1 Inhibitor with Potent Antileukemic ActivityJianyu Nie, Xiaojiao Sun, Yan He, et al.
RSC Advances|May 11, 2022
Discovery of acylphloroglucinol-based meroterpenoid enantiomers as KSHV inhibitors from <i>Hypericum japonicum</i>Linzhen Hu, Yanfei Liu, Yanxing Wang, et al.
European Journal of Medicinal Chemistry|August 20, 2021
Design, synthesis and biological activities of benzo[d]imidazo[1,2-a]imidazole derivatives as TRPM2-specfic inhibitorsSiqi Zhao, Han Zhang, Hongwei Jin, et al.
Chemistry & Biodiversity|February 24, 2026
Design, Synthesis, and Bioactivity Evaluation of a Palmitoyltransferase Inhibitor Based on the PAP StructureYibo Zhang, Han Liu, Jinze Li, et al.
Pageof 17